SCHEMBL1131479

SCHEMBL1131479

COC(=O)/C=C/c1cn(C2CCCCC2)c(-c2ccc(OCc3ccccc3)cc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
KDM4E B2RXH2 2/20 0.41
KMT2A Q03164 1/20 0.41
GSK3B P49841 1/20 0.40
BACE1 P56817 1/20 0.40
BTK Q06187 1/20 0.39
RAB9A P51151 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
IGF1R P08069 1/20 0.38
HTR3A P46098 2/20 0.38
MAP3K7 O43318 1/20 0.38
TAB1 Q15750 1/20 0.38
MAOB P27338 1/20 0.38
NPC1 O15118 1/20 0.38
NR1H4 Q96RI1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1131560 1.00 ALOX5 (0.43) ALOX5SMN1; SMN2KDM4EKMT2AGSK3B
SCHEMBL1131706 0.91 ALOX5 (0.42) ALOX5SMN1; SMN2KDM4EKMT2AGSK3B
SCHEMBL1131710 0.91 ALOX5 (0.42) ALOX5SMN1; SMN2KDM4EKMT2AGSK3B
SCHEMBL1131252 0.91 PRMT5 (0.41) ALOX5SMN1; SMN2KDM4EKMT2ABTK
SCHEMBL1131256 0.91 PRMT5 (0.41) ALOX5SMN1; SMN2KDM4EKMT2ABTK
SCHEMBL12860107 0.86 S1PR1 (0.38) SMN1; SMN2KDM4EKMT2ARAB9AALDH1A1
SCHEMBL12860137 0.85 CA12 (0.42) ALOX5KDM4EKMT2AALDH1A1HPGD
SCHEMBL1131481 0.84 PTPN1 (0.44) ALOX5SMN1; SMN2KDM4EKMT2ABTK
SCHEMBL1131573 0.84 PTPN1 (0.44) ALOX5SMN1; SMN2KDM4EKMT2ABTK
SCHEMBL1131258 0.81 ALOX5 (0.41) ALOX5SMN1; SMN2KDM4EKMT2ABTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663105-B1 CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2011-02-16 EP claimed
EP-1663105-B1 CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2011-02-16 EP disclosed